Mohsen Halaby,MD

Board-Certified Internal Medicine
Founder, carebridge medical
Primary Care | Weight Loss | metabolic health

[Mohsen Halaby,MD @HalabyMD]

@MoSalah شرفتونا ياأبطال

[Mohsen Halaby,MD @HalabyMD]

@IhabFathiSulima BCC

[Mohsen Halaby,MD @HalabyMD]

@modernHealthMe Genital warts HPV he should be worried

[Mohsen Halaby,MD @HalabyMD]

@MarioNawfal Lol AI

[Mohsen Halaby,MD @HalabyMD]

👉 Start your physician-guided weight loss plan:
https://t.co/DXoD3qNqne

Serving Ohio, California & Michigan

[Mohsen Halaby,MD @HalabyMD]

GLP-1 medications are changing weight loss.

But most people are using them wrong.

I see this often:
• No proper evaluation
• No lab work
• No long-term plan

That’s how you lose weight… and gain it back.

Used correctly, they can be life-changing.

👇 More in first reply

[Mohsen Halaby,MD @HalabyMD]

https://t.co/LMbMxRVCQY

[Mohsen Halaby,MD @HalabyMD]

Tired of long wait times, rushed visits, and fragmented care?

This is exactly why I built my own practice.

✔️ Direct access to a physician
✔️ Transparent pricing
✔️ Fully virtual care

Serving Ohio, California & Michigan

👇 Details in first reply

[Mohsen Halaby,MD @HalabyMD]

@IhabFathiSulima Discoid lupus erythematosus vs tinea

[Mohsen Halaby,MD @HalabyMD]

Retatrutide
A new obesity drug is showing weight loss results that may exceed current GLP-1 therapies.

But it’s important to understand what we actually know — and what we don’t yet.

Retatrutide, an investigational once-weekly triple agonist from Eli Lilly, targets three metabolic pathways (GLP-1, GIP, and glucagon). Early trials have shown substantial weight reduction.

However:
• It is still investigational
• It is not FDA-approved
• Long-term safety and cardiovascular outcomes are still being studied

At Carebridge Medical, our approach to metabolic health focuses on evidence-based medicine and individualized care.

For patients exploring medical weight management, we help review FDA-approved therapies, metabolic drivers, and sustainable treatment strategies.

If you're interested in the science behind Retatrutide and where it might fit in future obesity treatment, I wrote a deeper analysis here:

🔗 https://t.co/OOMEkfoqKf

#MetabolicHealth #ObesityMedicine #VirtualCare #MedicalWeightManagement

[Mohsen Halaby,MD @HalabyMD]

@SameerYogi14 @DrAkhilX @albertoortegana @Ausbones @ChShafiullah15 @daoo100 @DoctorMed0 @Dr_Akuabata24__ @dr_manish_ydv @DrMedica_13 @MedLearnHub @drxmelodyy Shingle

[Mohsen Halaby,MD @HalabyMD]

@NEJM trigeminal trophic syndrome (TTS)

[Mohsen Halaby,MD @HalabyMD]

The 7 pillars for Metabolic Health
https://t.co/ZKmfykIYQq

[Mohsen Halaby,MD @HalabyMD]

@ZahoorAhmed1450 A

[Mohsen Halaby,MD @HalabyMD]

@IhabFathiSulima Diabetic foot

[Mohsen Halaby,MD @HalabyMD]

A mind of gratitude, finding joy in small moments, learning from challenges, and valuing life.

[Mohsen Halaby,MD @HalabyMD]

@InvestorVideos Yep good call

[Mohsen Halaby,MD @HalabyMD]

@InvestorVideos What about AVGO?